Richard Keyme, MD
Physical Medicine and Rehabilitation · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 6 carriers
- Office
- 1
Offices
1 location · James Petros MD Inc · 21 clinicians in this group
Looking this up.
Plans that list them
29 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Keyme’s office at (408) 528-8833 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A133422 · Current
Licensed to practise in California · since 2014 · expires 2028-03-31 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$239,263
Medicare paid this office $239,263 for 239 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 196 | $76,983 | $109 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 184 | $44,583 | $71 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 147 | $37,617 | $77 |
| Long return visit (40+ min) | 53 | $19,344 | $164 |
| Administration of psychological or neuropsychological test, first 30 minutes | 126 | $8,107 | $39 |
See all 16 services
| Return visit (30+ min) | 196 | $76,983 | $109 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 184 | $44,583 | $71 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 147 | $37,617 | $77 |
| Long return visit (40+ min) | 53 | $19,344 | $164 |
| Administration of psychological or neuropsychological test, first 30 minutes | 126 | $8,107 | $39 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 40 | $6,387 | $125 |
| New patient visit (45+ min) | 42 | $6,018 | $143 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 71 | $5,813 | $51 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 146 | $5,493 | $14 |
| Short return visit (20+ min) | 27 | $3,079 | $81 |
| Injection of trigger points, 3 or more muscles | 31 | $2,623 | $55 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,889 | $63 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $1,778 | $99 |
| Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | 42 | $1,513 | $29 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 22 | $1,138 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 50 | $229 | None |
Who their Medicare patients are
239 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 12% · Women 67% · Also on Medicaid 14% · Health risk score 1.33. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Depression 36% · Diabetes 29% · Coronary heart disease 28% · Chronic kidney disease 22% · Atrial fibrillation 19% · COPD 16% · Heart failure 13% · Cancer 13% · Stroke 8%.
The office billed $2,767,763, Medicare allowed $317,748 and paid $239,263; for 3,448 services of 58 kinds; $243 of it was for drugs given in the office and $239,020 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 239 | 3,448 | 74 | 1.33 | $2,767,763 | $239,263 |
| 2023 | 310 | 3,605 | 73 | 1.33 | $4,086,586 | $306,041 |
| 2022 | 267 | 1,912 | 72 | 1.26 | $1,252,774 | $165,639 |
| 2021 | 147 | 332 | 72 | 1.72 | $229,092 | $32,258 |
| 2020 | 257 | 411 | 75 | 1.97 | $98,504 | $36,404 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Return visit (30+ min) | 242 | $129,807 | $119 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 251 | $68,820 | $74 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 125 | $13,088 | $75 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 66 | $12,607 | $133 |
| New patient visit (45+ min) | 77 | $11,961 | $155 |
| Administration of psychological or neuropsychological test, first 30 minutes | 166 | $9,198 | $41 |
| Insertion of peripheral nerve neurostimulator electrode through skin | 19 | $9,078 | $227 |
| Long return visit (40+ min) | 16 | $5,465 | $166 |
| Injection of trigger points, 3 or more muscles | 44 | $3,525 | $54 |
| New patient visit (60+ min) | 17 | $3,241 | $191 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 40 | $3,013 | $56 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 56 | $2,943 | $41 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $2,289 | $109 |
| Short return visit (20+ min) | 24 | $2,269 | $81 |
| Injection of substance into middle or upper spine canal using imaging guidance | 18 | $2,226 | $97 |
| Aspiration and/or injection of fluid from large joint | 20 | $2,095 | $68 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,421 | $79 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 11 | $1,020 | $73 |
| Ultrasonic guidance for needle placement | 12 | $574 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 64 | $326 | None |
2022: 16 services
| Return visit (30+ min) | 205 | $81,215 | $120 |
| Short return visit (20+ min) | 96 | $14,474 | $83 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 18 | $9,921 | $551 |
| New patient visit (45+ min) | 50 | $7,278 | $146 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 38 | $5,903 | $128 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 41 | $5,594 | $77 |
| Long return visit (40+ min) | 23 | $5,108 | $165 |
| Administration of psychological or neuropsychological test, first 30 minutes | 95 | $4,582 | $44 |
| Injection of trigger points, 3 or more muscles | 42 | $4,225 | $57 |
| Injection of trigger points, 1-2 muscles | 50 | $2,829 | $50 |
| Aspiration and/or injection of fluid from large joint | 28 | $2,339 | $65 |
| Muscle electrical test | 13 | $2,335 | $106 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 32 | $1,886 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | $276 | None |
| Testing for presence of drug, read by direct observation | 12 | $150 | $13 |
| Assessment of emotional or behavioral problems | 13 | $66 | $5 |
2021: 7 services
| Return visit (30+ min) | 51 | $10,645 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $6,117 | $111 |
| Short return visit (20+ min) | 19 | $2,451 | $91 |
| New patient visit (45+ min) | 12 | $1,966 | $164 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,609 | $85 |
| Administration of psychological or neuropsychological test, first 30 minutes | 25 | $1,318 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $657 | $60 |
2020: 6 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 165 | $19,238 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $6,766 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,687 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,077 | $87 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,542 | $33 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,354 | $85 |
Drugs they prescribed that Part D paid
$64,287
Pharmacies billed $64,287 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 44% of their Part D prescriptions (519 of 1,189) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 11% of their opioid prescriptions.
1,141 generic and 48 brand-name prescriptions · $64,287 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nucynta Er | 11 | $13,305 | $1,210 |
| Buprenorphine-Naloxone | 75 | $8,235 | $110 |
| Hydrocodone-Acetaminophen | 243 | $6,018 | $25 |
| Gabapentin | 99 | $2,927 | $30 |
| Oxycodone | 91 | $2,635 | $29 |
See all 21 drugs
| Nucynta Er | 11 | $13,305 | $1,210 |
| Buprenorphine-Naloxone | 75 | $8,235 | $110 |
| Hydrocodone-Acetaminophen | 243 | $6,018 | $25 |
| Gabapentin | 99 | $2,927 | $30 |
| Oxycodone | 91 | $2,635 | $29 |
| Buprenorphine | 64 | $2,351 | $37 |
| Lidocaine | 13 | $1,929 | $148 |
| Oxycodone-Acetaminophen | 78 | $1,504 | $19 |
| Pregabalin | 49 | $1,075 | $22 |
| Cyclobenzaprine | 84 | $681 | $8 |
| Tizanidine | 44 | $564 | $13 |
| Celecoxib | 23 | $504 | $22 |
| Amitriptyline | 41 | $455 | $11 |
| Morphine Sulfate Er | 11 | $434 | $39 |
| Hydromorphone | 18 | $349 | $19 |
| Duloxetine | 12 | $340 | $28 |
| Trazodone | 24 | $173 | $7 |
| Baclofen | 25 | $144 | $6 |
| Tramadol | 22 | $128 | $6 |
| Methadone | 11 | $112 | $10 |
| Zolpidem | 18 | $91 | $5 |
Year by year
| 2024 | 1,189 | 149 | 44% (519) | 4% | $64,287 |
| 2023 | 1,220 | 127 | 48% (583) | 5% | $66,989 |
| 2022 | 1,220 | 175 | 49% (598) | 6% | $91,727 |
| 2021 | 149 | 58 | 52% (77) | 13% | $25,963 |
| 2020 | 13 | None | None | 0% | $396 |
| 2019 | 75 | 26 | 37% (28) | None | $2,444 |
| 2018 | 51 | 21 | 26% (13) | None | $1,593 |
| 2014 | 13 | None | None | 0% | $112 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Hydrocodone-Acetaminophen | 215 | $6,443 | $30 |
| Oxycodone-Acetaminophen | 125 | $3,741 | $30 |
| Oxycontin | 12 | $3,345 | $279 |
| Gabapentin | 102 | $3,328 | $33 |
| Buprenorphine-Naloxone | 38 | $3,293 | $87 |
| Oxycodone | 111 | $2,750 | $25 |
| Pregabalin | 45 | $1,804 | $40 |
| Buprenorphine | 51 | $1,310 | $26 |
| Tizanidine | 40 | $853 | $21 |
| Celecoxib | 22 | $776 | $35 |
| Cyclobenzaprine | 68 | $662 | $10 |
| Amitriptyline | 46 | $527 | $11 |
| Morphine Sulfate | 17 | $447 | $26 |
| Carisoprodol | 19 | $391 | $21 |
| Cephalexin | 11 | $357 | $32 |
| Tramadol | 29 | $270 | $9 |
| Hydromorphone | 22 | $246 | $11 |
| Clonidine | 20 | $233 | $12 |
| Baclofen | 21 | $224 | $11 |
| Methadone | 17 | $200 | $12 |
| Trazodone | 23 | $180 | $8 |
| Zolpidem | 21 | $106 | $5 |
| Prednisone | 20 | $38 | $2 |
2022: 21 drugs
| Belbuca | 15 | $7,574 | $505 |
| Hydrocodone-Acetaminophen | 208 | $5,603 | $27 |
| Oxycodone-Acetaminophen | 112 | $3,624 | $32 |
| Gabapentin | 103 | $2,900 | $28 |
| Oxycodone | 136 | $2,291 | $17 |
| Buprenorphine | 41 | $1,982 | $48 |
| Pregabalin | 50 | $1,796 | $36 |
| Baclofen | 32 | $1,610 | $50 |
| Buprenorphine-Naloxone | 20 | $1,499 | $75 |
| Cyclobenzaprine | 46 | $1,176 | $26 |
| Duloxetine | 13 | $1,136 | $87 |
| Celecoxib | 18 | $647 | $36 |
| Tramadol | 36 | $579 | $16 |
| Tizanidine | 57 | $577 | $10 |
| Amitriptyline | 39 | $427 | $11 |
| Morphine Sulfate | 16 | $405 | $25 |
| Hydromorphone | 29 | $386 | $13 |
| Carisoprodol | 17 | $289 | $17 |
| Trazodone | 21 | $78 | $4 |
| Cephalexin | 11 | $64 | $6 |
| Prednisone | 19 | $37 | $2 |
2021: 2 drugs
| Hydrocodone-Acetaminophen | 26 | $700 | $27 |
| Cephalexin | 11 | $89 | $8 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 19 | $349 | $18 |
Money from drug and device companies
$58 in 2025
| 2025 | 1 | 1 | None | $58 |
| 2024 | 5 | 16 | None | $338 |
| 2023 | 7 | 35 | None | $1,097 |
| 2022 | 7 | 18 | None | $681 |
| 2021 | 4 | 14 | None | $293 |
| 2020 | 1 | 1 | None | $126 |
| 2019 | 7 | 12 | None | $233 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mml US | Reactiv8 | $58 | 1 payment
|
See the published payment
| Mml US | Meals · 2025-09-25 | Reactiv8 | $58 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $338
| Boston Scientific | None | $175 | 8 payments
|
| Abbott Laboratories | Proclaim | $77 | 4 payments
|
| Electronic Waveform Lab | None | $41 | 2 payments
|
| Vertos Medical | Mild Device Kit | $24 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $21 | 1 payment
|
2023: $1,097
| Boston Scientific | Wavewriter Alpha Prime 16 | $482 | 14 payments
|
| SPR Therapeutics | Sprint Pns System | $301 | 5 payments
|
| Nalu Medical | Nalu Neurostimulation System | $115 | 5 payments
|
| Collegium Pharmaceutical | Belbuca | $78 | 4 payments
|
| Electronic Waveform Lab | None | $55 | 4 payments
|
| Pfizer | Comirnaty | $39 | 2 payments
|
| Masimo | Patient Safetynet System | $27 | 1 payment
|
2022: $681
| SPR Therapeutics | Sprint Pns System | $226 | 3 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $214 | 5 payments
|
| Boston Scientific | General - Pain Management | $142 | 4 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $32 | 2 payments
|
| Nalu Medical | Nalu Neurostimulation System | $30 | 2 payments
|
| Hikma Pharmaceuticals USA | Kloxxado | $22 | 1 payment
|
| Vertos Medical | Mild Device Kit | $14 | 1 payment
|
2021: $293
| Boston Scientific | General Pain Management | $232 | 10 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $27 | 2 payments
|
| AbbVie | Qulipta | $23 | 1 payment
|
| Vertos Medical | Mild Device Kit | $11 | 1 payment
|
2020: $126
| Penumbra | Real System | $126 | 1 payment
|
2019: $233
| Zimmer Biomet Holdings | Accufill | $71 | 1 payment
|
| Electronic Waveform Lab | None | $53 | 5 payments
|
| Assertio Therapeutics | Gralise | $35 | 2 payments
|
| Bioventus | Durolane | $23 | 1 payment
|
| Boston Scientific | Spectra Wavewriter | $19 | 1 payment
|
| Pfizer | Lyrica | $17 | 1 payment
|
| Allergan | Botox | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1174866107
- Licence
- CA A133422, NV 19411California A133422: Current · expires 2028-03-31
- Group
- James Petros MD Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X); Federal specialty code 2081P0301X (2081P0301X); Federal specialty code 2081P2900X (2081P2900X)
- Mailing address
- 1604 Blossom Hill Rd Ste 10, San Jose, CA, 95124
- NPI first listed
- 2013-03-27
- NPI last updated
- 2022-07-21
- NPI record certified
- 2021-08-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3249 Oak Park Ave, Berwyn, IL, 60402 · 3801 Miranda Ave, Palo Alto, CA, 94304 · 651 Wildwood Ln, Palo Alto, CA, 94303 · 1495 Mill St, Reno, NV, 89502
This office lists an electronic records connection.